Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Апрель 26, 2024
Gynecologic
cancers,
including
ovarian
cancer
(OC),
cervical
(CC),
and
endometrial
(EC),
pose
a
serious
threat
to
women's
health
quality
of
life
due
their
high
incidence
lethality.
Therapeutic
resistance
in
tumors
refers
reduced
sensitivity
tumor
cells
therapeutic
drugs
or
radiation,
which
compromises
the
efficacy
treatment
renders
it
ineffective.
significantly
contributes
failure
gynecologic
tumors,
although
specific
molecular
mechanisms
remain
unclear.
Exosomes
are
nanoscale
vesicles
released
received
by
distinct
kinds
cells.
contain
proteins,
lipids,
RNAs
closely
linked
origins
functions.
Recent
studies
have
demonstrated
that
exosomal
ncRNAs
may
be
involved
intercellular
communication
can
modulate
progression
tumorigenesis,
aggravation
metastasis,
microenvironment
(TME),
drug
resistance.
Besides,
also
potential
become
significant
diagnostic
prognostic
biomarkers
various
diseases.
In
this
paper,
we
reviewed
biological
roles
as
well
explored
acting
liquid
biopsy
markers
cancers.
Journal of Experimental & Clinical Cancer Research,
Год журнала:
2025,
Номер
44(1)
Опубликована: Янв. 14, 2025
Abstract
Background
Most
patients
with
prostate
cancer
inevitably
progress
to
castration-resistant
(CRPC),
at
which
stage
chemotherapeutics
like
docetaxel
become
the
first-line
treatment.
However,
chemotherapy
resistance
typically
develops
after
an
initial
period
of
therapeutic
efficacy.
Increasing
evidence
indicates
that
stem
cells
confer
via
exosomes.
This
study
demonstrated
AGD1,
derived
from
(PCSCs),
enhanced
stemness
and
reduced
effect
in
CRPC.
Methods
Quantitative
real-time
PCR
(qPCR)
was
employed
determine
expression
levels
AGD1
METTL13
mRNAs
PCSCs
Protein
were
examined
using
western
blots
dot
blots.
The
potential
functions
CRPC
investigated
through
cell
proliferation
assay,
Transwell
EdU
incorporation
assays,
Annexin
V-FITC/PI
staining,
sphere
formation
assays.
To
uncover
underlying
mechanisms
RNA
pull-down
RIP,
co-Immunoprecipitation
(co-IP),
mass
spectrometry
(MS),
Methylated
immunoprecipitation
(MeRIP)
single-base
elongation
ligation-based
qPCR
amplification
method
(SELECT)
performed.
effects
on
development
metastasis
under
treatment
analyzed
a
xenograft
mouse
model
organoid
model.
Additionally,
liposomal-chitosan
nanocomplex
drug
delivery
systems
designed
explore
AGD1’s
role
regulating
Results
upregulated
Downregulating
sensitivity
by
inhibiting
their
stemness,
reverse
also
being
true.
pull-down,
combined
MS,
co-IP
RIP
binds
USP10,
forming
complex
facilitates
protein
accumulation
USP10-induced
deubiquitination.
MeRIP
assay
SELECT
revealed
transcriptionally
controls
mRNA
decay
CD44
m6A
methylation.
this
process
activates
pSTAT3/PI3K-AKT
signaling
pathway.
Organoid
models
showed
reducing
Conclusions
mediates
apoptosis
promotes
enhancing
tumor
growth
USP10/METTL13-mediated
Abstract
Glioblastoma
multiforme
(GBM),
a
WHO
grade
IV
diffuse
glioma,
is
highly
aggressive
brain
tumor
with
median
survival
of
less
than
year.
Characterized
by
robust
proliferation
and
invasion,
recent
studies
spotlight
glioma
stem
cells
(GSCs)
within
GBM
tumors,
pivotal
in
development,
progression,
treatment
resistance.
This
review
aims
to
shed
light
on
the
critical
role
GSCs
initiation
progression
GBM,
emphasizing
their
contribution
development
resistance
existing
treatments.
Unlike
normal
cells,
play
pathogenesis.
The
delves
into
unique
characteristics
GSCs,
marked
heightened
metabolic
activities
distinct
epigenetic
transcriptional
programming.
Recognizing
significance
years,
examines
how
presence
amplifies
lethal
nature
GBM.
also
critically
evaluates
advancements
diagnostic
methods
therapies,
which
include
targeting
GSCs.
Providing
concise
yet
comprehensive
overview,
contributes
insights
GBM's
intricate
dynamics,
offering
potential
directions
for
future
research
therapeutic
strategies.
Cell Communication and Signaling,
Год журнала:
2024,
Номер
22(1)
Опубликована: Фев. 15, 2024
Abstract
In
recent
decades,
emerging
data
have
highlighted
the
critical
role
of
extracellular
vesicles
(EVs),
especially
(exosomes)
Exos,
in
progression
and
development
several
cancer
types.
These
nano-sized
are
released
by
different
cell
lineages
within
niche
maintain
a
suitable
platform
for
interchange
various
signaling
molecules
paracrine
manner.
Based
on
studies,
Exos
can
transfer
oncogenic
factors
to
other
cells,
alter
activity
immune
tumor
microenvironment,
leading
expansion
cells
metastasis
remote
sites.
It
has
been
indicated
that
cell-to-cell
crosstalk
is
so
complicated
wide
array
involved
this
process.
How
which
mechanisms
regulate
behavior
non-cancer
at
center
debate.
Here,
we
scrutinize
molecular
parenchyma.
Besides,
tumoricidal
properties
from
stem
(SC)
types
discussed
detail.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2025,
Номер
13
Опубликована: Фев. 19, 2025
Extracellular
vesicles
(EVs)
are
nano-sized,
membranous
structures
secreted
by
cells
into
the
extracellular
space,
have
attracted
considerable
attention
in
field
of
biosciences
for
their
role
intercellular
communication
various
physiological
and
pathological
processes.
Their
ubiquitous
presence
bodily
fluids
cell-specific
characteristics
make
them
promising
candidates
as
biomarkers.
Additionally,
ability
to
transport
biological
therapeutics
across
different
barriers
specific
target
underscores
significant
translational
potential
diagnostic
therapeutic
purposes.
Significant
progress
has
been
achieved
translation
EVs
research
clinical
applications,
however,
challenges
persist
large-scale
production
EVs,
particularly
areas
scalable
manufacturing,
efficient
isolation
methods,
drug
loading
techniques,
advanced
characterization
technology.
This
review
critically
examines
complex
processes
involved
biogenesis
explores
recent
developments
production.
By
synthesizing
knowledge
from
these
fields,
this
aims
provide
a
holistic
perspective
on
evolving
landscape
its
underscoring
both
accomplishments
obstacles
that
lie
ahead
fully
realizing
biomedicine.
Heliyon,
Год журнала:
2024,
Номер
10(6), С. e27306 - e27306
Опубликована: Март 1, 2024
Currently,
stem
cells
are
a
prominent
focus
of
regenerative
engineering
research.
However,
due
to
the
limitations
commonly
used
cell
sources,
their
application
in
therapy
is
often
restricted
experimental
stage
and
constrained
by
ethical
considerations.
In
contrast,
urine-derived
(USCs)
offer
promising
advantages
for
clinical
trials
applications.
The
noninvasive
nature
collection
process
allows
repeated
retrieval
within
short
period,
making
it
more
feasible
option.
Moreover,
studies
have
shown
that
USCs
protective
effect
on
organs,
promoting
vascular
regeneration,
inhibiting
oxidative
stress,
reducing
inflammation
various
acute
chronic
organ
dysfunctions.
has
also
been
enhanced
advancements
biomaterials
technology,
enabling
better
targeting
controlled
release
capabilities.
This
review
aims
summarize
current
state
research
USCs,
providing
insights
future
applications
basic
settings.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(13), С. 11054 - 11054
Опубликована: Июль 4, 2023
Alzheimer’s
disease
(AD)
and
Parkinson’s
(PD)
are
the
most
common
neurodegenerative
diseases
(NDDs)
threatening
lives
of
millions
people
worldwide,
including
especially
elderly
people.
Currently,
due
to
lack
a
timely
diagnosis
proper
intervention
strategy,
AD
PD
largely
remain
incurable.
Innovative
therapy
highly
desired.
Exosomes
small
vesicles
that
present
in
various
bodily
fluids,
which
contain
proteins,
nucleic
acids,
active
biomolecules,
play
crucial
role
intercellular
communication.
In
recent
years,
exosomes
pathogenesis,
early
diagnosis,
treatment
has
attracted
ascending
attention.
However,
exact
pathogenesis
theragnostic
not
been
fully
illustrated.
review,
we
first
introduce
biogenesis,
components,
uptake,
function
exosomes.
Then
elaborate
on
involvement
PD.
Moreover,
application
therapeutics
is
also
summarized
discussed.
Additionally,
serving
as
drug
carriers
deliver
medications
central
nervous
system
specifically
addressed.
The
potential
explored,
discussing
their
applications
treatment,
well
current
limitations.
Given
limitation
exosomes,
propose
future
perspectives
for
better
utilizing
NDDs.
Hopefully,
it
would
pave
ways
expanding
biological
fundamental
research
theranostics
Abstract
Extracellular
vesicles
(EVs)
have
emerged
as
valuable
biological
materials
for
treating
intractable
diseases.
Extensive
studies
are
conducted
on
EVs
derived
from
various
cellular
sources.
In
this
study,
Lactobacillus
reuteri
(
L.
),
a
probiotic,
exhibit
remarkable
cancer
therapeutic
efficacy
when
administered
orally
is
reported.
These
‐derived
(REVs)
demonstrate
stability
in
the
gastrointestinal
tract
and
exert
significant
anti‐tumor
effects.
Using
A549
cells
murine
models,
we
confirmed
that
REVs
mediate
their
effects
by
modulating
apoptotic
signaling
pathways.
Furthermore,
combination
of
REV
with
drugs
enhances
tumor
ablation
induces
immunogenic
cell
death.
mouse
model,
oral
administration
encapsulating
indocyanine
green
followed
photothermal
therapy
led
to
complete
elimination
within
32
days.
represent
promising
platform
treatment,
either
independently
or
other
therapies,
depending
treatment
objectives.
Abstract
The
success
of
cancer
therapy
has
been
significantly
hampered
by
various
mechanisms
therapeutic
resistance.
Chief
among
these
is
the
presence
clonal
heterogeneity
within
an
individual
tumor
mass.
introduction
concept
stem
cells
(CSCs)—a
rare
and
immature
subpopulation
with
tumorigenic
potential
that
contributes
to
intratumoral
heterogeneity—has
deepened
our
understanding
drug
Given
characteristics
CSCs,
such
as
increased
drug‐efflux
activity,
enhanced
DNA‐repair
capacity,
high
metabolic
plasticity,
adaptability
oxidative
stress,
and/or
upregulated
detoxifying
aldehyde
dehydrogenase
(ALDH)
enzymes,
CSCs
have
recognized
a
theoretical
reservoir
for
resistant
diseases.
Implicit
in
this
recognition
possibility
CSC‐targeted
strategies
might
offer
breakthrough
overcoming
resistance
patients.
Herein,
we
summarize
generation
current
underlying
CSC‐mediated
This
extended
knowledge
progressively
translated
into
novel
anticancer
enriched
available
options
combination
treatments,
all
which
are
anticipated
improve
clinical
outcomes
patients
experiencing
CSC‐related
relapse.